X-LINKED RETINOSCHISIS
Clinical trials for X-LINKED RETINOSCHISIS explained in plain language.
Never miss a new study
Get alerted when new X-LINKED RETINOSCHISIS trials appear
Sign up with your email to follow new studies for X-LINKED RETINOSCHISIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy trial aims to save sight in boys and men with rare retinal disease
Disease control Recruiting nowThis study tests a gene therapy called ATSN-201 in males aged 6 and older with X-linked retinoschisis, a genetic eye condition that leads to vision loss. The therapy delivers a working copy of the RS1 gene to the retina. The trial has three parts: first, finding the right dose; s…
Matched conditions: X-LINKED RETINOSCHISIS
Phase: PHASE3 • Sponsor: Atsena Therapeutics Inc. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New study aims to sharpen vision tests for the blind
Knowledge-focused Recruiting nowThis study enrolls 25 people with severe retinal diseases like retinitis pigmentosa and Stargardt disease to test new ways of measuring visual function. Researchers will evaluate how well participants can perform various vision tests, such as navigating obstacles or detecting lig…
Matched conditions: X-LINKED RETINOSCHISIS
Sponsor: Ray Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC